HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideaki Amada Selected Research

TP0438836

12/2018Discovery of a potent, low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor (TP0438836) for the treatment of type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideaki Amada Research Topics

Disease

1Infections
01/2021
1Type 2 Diabetes Mellitus (MODY)
12/2018
1Alopecia (Baldness)
01/2013

Drug/Important Bio-Agent (IBA)

1Anti-Infective Agents (Microbicides)IBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
12/2018
1SodiumIBA
12/2018
1TP0438836IBA
12/2018
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2013
1benzothiazoleIBA
01/2013
1Pharmaceutical PreparationsIBA
01/2013